Apoptosis dysregulation in human gastric carcinomas: Relationship to anti- and pro-apoptotic protein expression

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 1, 2007, Pages 45-50

  Nasif, Wesam A ^a   El Emshaty, Hoda M ^b   Lotfy, Mahmoud ^a   Zalata, Khaled ^b   El Hak, Nabil G ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Bax; Bcl 2; Gastric cancer; P53

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34547744450     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Attallah AM, El-Hak NG, Nasif WA, Tabll A, Ezzat F (1997). Detection of p53 protein overexpression and DNA ploidy analysis in colon cancer. Hepatogastroenterology, 44, 1595-601.
2. Bani-Hani KE, Almasri NM, Khader YS, Sheyab FM, Karam HN (2005). Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Clin Cancer Res, 11, 1447-53.
3. Carson DA, Lois A (1995). Cancer prognosis and p53. Lancet, 346, 1251-4.
4. Charalambous GK, Gomatos IP, Konstadoulakis MM, et al. (2000). Protein expression of Bax, Bcl-2, and p53 in patients with Non-Hodgkin's gastric lymphoma: Prognostic significance. World J Surg, 24, 608-14.
5. Chen XT, Ai ZL, Liu ZS (2000). Apoptosis-study on the mechanism of hepatic cell injury by mitomycin. Shijie Huaren Xiaohua Zazhi, 8, 746-50.
6. Craig RW (1995). The Bcl-2 gene family. Semin Cancer Biol, 6, 35.
7. Deng LY, Zhang YH, Xu P, Yang SM, Yuan XB (1999). Expression of interleukin 1 converting enzyme in 5-FU induced apoptosis in esophageal carcinoma cells. World J Gastroenterology, 5, 50-2.
8. Eissa S, Seada LS (1998). Quantitation of Bcl-2 protein in bladder cancer tissue by enzyme immunoassay: Comparison with Western blot and immunohistochemistry. Clin Chem, 44, 1423-9.
9. Guo X-Z, Shao X-D, Liu M-P, et al. (2002). Effect of Bax, Bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J Gastroenterol, 8, 1059-62.
10. Hino N, Higashi T, Nouso K, Nakatsukasa H, Tsuji T (1996). Apoptosis and proliferation of human hepatocellular carcinoma. Liver, ?, 123-9.
11. Hockenbery D, Nunez G, Milliman C, Schreieber RD, Korsmeyer SJ (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334.
12. Ikeda M, Shomori K, Endo K, et al. (1998). Frequent occurrence of apoptosis and event in the oncogenesis of human gastric carcinoma. Virchows Arch, 432, 43-7.
13. Ishida M, Gomyo Y, Tatebe S, Ohfuji S, Ito H (1996). Apoptosis in human gastric mucosa, chronic gastritis, dysplasia, and carcinoma: Analysis by terminal deoxynucleotidyl transferase mediated dUTP biotin nick end labeling. Virchows Arch, 428, 229-35.
14. Kandouz M, Gompel A, Therwath A (1996). Bcl-2 protooncogene apoptosis and oncogenesis: An overview. Int J Oncol, 9, 563-6.
15. Kasagi N, Somyo Y, Shira H, Tsujitani S, Ito H (1994). Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase- mediated dUTP-biotin nick end labeling. Jpn J Cancer Res, 84, 939-45.
16. Kesari AL, Chellam VG, Madhavan J, Nair PP, Pillai MR (1997). Expression of the antiapoptotic protein Bcl-2 is not dependent on tumor suppressor p53 protein in India breast carcinoma. Pathology, 65, 108-12.
17. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvi ZN (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol, 4, 327-32.
18. Koshida Y, Saegusa M, Okayasu I (1997). Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: Immunohistochemical and clinicopathological study. Br J Cancer, 75, 467-73.
19. Krajewski S, Krajewska M, Shabaik A, et al. (1994). Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol, 145, 1323-36.
20. Lan H, Lu Y (2004). Allitridi induces apoptosis by affectiing Bcl-2 expression and caspase-3 activity in human gastric cancer cells. Acta Pharmacologica Sinica, 25, 219-25.
21. Lan J, Xiong YY, Lin YX, et al. (2003). Helicobacter pylori infection generated gastric cancer through p53-Rb tumorsuppressor system mutation and telomerase reactivation. World J Gastroenterol, 9, 54-8.
22. Masutani M, Suzuki J-I, Matsuda T, et al. (2001). Increased apoptosis associated with depressed type of early intestinal gastric cancer. Jpn J Cancer Res, 92, 1214-9.
23. Liu HF, Liu WW, Fang DC (1999). Study of the relationship between apoptosis and proliferation in gastric carcinoma and its precancerous lesion. Shijie Huaren Xiaohua Zazhi, 7, 649-51.
24. Liu HF, Liu WW, Fang DC, Men RP (1998). Relationship between Fas antigen expression and apoptosis in human gastric carcinoma and adjacent non-cancerous tissues. Huaren Xiaohua Zazhi, 6, 321-2.
25. Nomura M, Shimizu S, Sugiyama T, et al. (2003). 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem, 278, 2058-65.
26. Puthalakath H, Strasser A (2002). Keeping killers on a tight leash: transcriptional and post-translational control of the proapoptotic activity of BH3-only proteins (Review). Cell Death Differ, 9, 505-12.
27. Reed JC (1994). Bcl-2 and the regulation of programmed cell death. J Cell Biol, 124, 1-6.
28. Reed JC (1997). Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematological malignancies. Semin Hematol, 34, 9-19.
29. Saegusa M, Takano Y, Okayasu I (1995). Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol, 121, 357-63.
30. Sundblad AS, Tamayo R (1995). Expression of MIB-1/ki 67 and Bcl-2 in gastric carcinoma: Relationship with clinicopathological factors. Acta Gastoenterol Latin Am, 25, 67-72.
31. Tahara E (1995). Genetic alterations in human gastrointestinal cancers: The application to molecular diagnosis. Cancer, 75, 1410-7.
32. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-62.
33. Wu MS, Shun GT, Lee WC, et al. (1998). Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer. Br J Cancer, 78, 971-3.
34. Xu AG, Li SG, Liu JH, Gan AH (2001). Function of apoptosis and expression of the proteins Bcl-2, p53 and C-Myc in the development of gastric cancer. World J Gastroenterol, 7,403-6.
35. Yang JQ, Yang LE, Zhu HC (2001). Mitomycin induces apoptosis of human hepatic cancer cell. Shijie Huaren Xiaohua Zazhi, 9, 268-72.
36. Ye J, Wu YL, Zhang S, et al. (2005). Inhibitory effect of human telomerase antisense oligodeoxyribonucleotides on the growth of gastric cancer cell lines in variant tumor pathological subtypes. World J Gastroenterol, 11, 2230-7.
37. Zhan Q, Fan S, Bae I, et al. (1994). Induction of Bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9, 3743-51.
38. Zhao AG (2000). Herbs induce apoptosis of human gastric cancer grafted onto Nude mice. Shijie Huaren Xiaohua Zazhi, 8, 737-740